SuanFarma

SuanFarma

SuanFarma functions as a vertically integrated pharmaceutical platform, bridging API distribution and contract development and manufacturing. The firm serves more than 400 active customers through a network of 10 area offices spanning Europe, the Americas, Asia, and Africa. Its product lines cover human APIs, veterinary APIs, intermediates, and nutraceutical ingredients, with dedicated divisions for each category. The firm's manufacturing footprint rests on two European production sites: the Cipan facility in Lisbon, Portugal, and the Rovereto plant in Italy. Both sites combine fermentation and chemical synthesis capabilities for complex small-molecule APIs and offer CDMO services to pharmaceutical innovators. The company maintains regulatory certifications from the world's leading health agencies and applies flow-chemistry technology to improve process control and sustainability at GMP scale. A recent technical article flagged data-integrity protocols across its API distribution chain (per SuanFarma, April 2026). With sales into more than 70 countries, SuanFarma's commercial reach extends from its Madrid headquarters to direct offices in Mexico City, São Paulo, Bogotá, Navi Mumbai, Shanghai, Fair Lawn, New Jersey, Algiers, and Moscow. Recent plant-level communications indicate active capacity expansion at the Rovereto site directed by the plant director (per SuanFarma, May 2026). What structurally differentiates SuanFarma is the combination of a global API merchant operation with captive European manufacturing and a CDMO arm. This allows the firm to internalize supply chain control from raw material selection through finished-dosage support — a posture that sits between pure-play distributors and standalone contract manufacturers.